NCT03801525 · Interventional trial
Study to Assess the Efficacy and Safety of Ublituximab in Combination With Umbralisib and Venetoclax Compared to Ublituximab in Combination With Umbralisib in Subjects With CLL (ULTRA-V)
Overall registry status Terminated
Phase 2 · Phase 3
Conditions Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Delaware Valley sites
- TG Therapeutics Investigational Trial Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory